» Articles » PMID: 11692182

Early-onset Type II Diabetes Mellitus in Italian Families Due to Mutations in the Genes Encoding Hepatic Nuclear Factor 1 Alpha and Glucokinase

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2001 Nov 3
PMID 11692182
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Maturity-onset-diabetes of the young (MODY) is caused by mutations in at least five different genes. Our aim was to determine the prevalence of the most common MODY genes in Italian families with early-onset Type II (non-insulin-dependent) diabetes mellitus.

Methods: We screened 28 Italian early-onset Type II diabetic families (diagnosis < 35 years) for mutations in the hepatic nuclear factor-4 alpha, (MODY1), glucokinase (MODY2) and hepatic nuclear factor-1 alpha (MODY3). Both strands of exons, flanking introns and minimal promoter regions of the above-mentioned genes were amplified using polymerase chain reaction and were sequenced directly.

Results: We identified four different mutations, three of which are not described, (W113X, G42P43fsCC --> A, H514R) and four new polymorphisms (G184G, T513T, IVS3-nt47delG, IVS1- nt53C --> G) in the hepatic nuclear factor-1 alpha gene, two new potential mutations (G44S, IVS4nt + 7C --> T) and three new polymorphisms (promoter-nt84C --> G, IVS9 + nt8C --> T, IVS9 + nt49G --> A) in the glucokinase gene, and a new polymorphism (IVS1c-nt11T --> G) in the hepatic nuclear factor-4 alpha gene.

Conclusion/interpretation: Mutations in the hepatic nuclear factor-1 alpha and glucokinase are associated with Type II diabetes in 14 % and 7 % of Italian families, respectively. Our findings provide an impetus for screening Italian MODY and early-non Type II diabetic families for mutations in the above mentioned genes to identify relatives at risk who could benefit from primary prevention care. [

Citing Articles

Identification of appropriate biochemical parameters and cut points to detect Maturity Onset Diabetes of Young (MODY) in Asian Indians in a clinic setting.

Aarthy R, Aston-Mourney K, Amutha A, Mikocka-Walus A, Anjana R, Unnikrishnan R Sci Rep. 2023; 13(1):11408.

PMID: 37452084 PMC: 10349068. DOI: 10.1038/s41598-023-37766-x.


Identification of Variants Responsible for Monogenic Forms of Diabetes in Brazil.

Abreu G, Tarantino R, Proenca da Fonseca A, Andrade J, de Souza R, Soares C Front Endocrinol (Lausanne). 2022; 13:827325.

PMID: 35592779 PMC: 9110842. DOI: 10.3389/fendo.2022.827325.


A Comprehensive Analysis of Hungarian MODY Patients-Part II: Glucokinase MODY Is the Most Prevalent Subtype Responsible for about 70% of Confirmed Cases.

Gaal Z, Szucs Z, Kantor I, Luczay A, Toth-Heyn P, Benn O Life (Basel). 2021; 11(8).

PMID: 34440516 PMC: 8400228. DOI: 10.3390/life11080771.


Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.

Breidbart E, Deng L, Lanzano P, Fan X, Guo J, Leibel R J Pediatr Endocrinol Metab. 2021; 34(5):633-638.

PMID: 33852230 PMC: 8970616. DOI: 10.1515/jpem-2020-0501.


Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel , and Mutations.

Alvelos M, Goncalves C, Coutinho E, Almeida J, Bastos M, Sampaio M J Clin Med. 2020; 9(1).

PMID: 31968686 PMC: 7019520. DOI: 10.3390/jcm9010288.